Defective OGG1 mutants do not excise FapyG

Stable Identifier
R-HSA-9656252
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

OGG1 R46Q mutant, reported in renal carcinoma, and OGG1 R154H mutant, reported in stomach cancer cell line MKN4 (Bruner et al. 2000), show decreased excision of FapyG from dsDNA (Audebert, Radicella et al. 2000), with the function of OGG1 R154H being more severely impaired. It is uncertain whether binding to FapyG in dsDNA substrate is affected in OGG1 R46Q and OGG1 R154H.
OGG1 R46L has not been functionally studied but has been reported in cancer and predicted to be pathogenic. It is annotated as a candidate disease variant based on its similarity with OGG1 R46L.
OGG1 S326C is a frequent genetic polymorphism in people of European and Asian descent. OGG1 S326C variant is susceptible to oxidative modifications, leading to diminished catalytic activity (Yamane et al. 2004, Moritz et al. 2014) under conditions of oxidative stress (Kershaw and Hodges 2012). This may be due to decreased specificity of OGG1 S326C for FapyG (Dherin et al. 1999).

Literature References
Participants
Participant Of
Normal reaction
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created